- Home
- CLDI vs BMRA Comparison
CLDI vs BMRA Comparison
Compare CLDI & BMRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLDI
- BMRA
- Stock Information
- Founded
- CLDI 2014
- BMRA 1971
- Country
- CLDI United States
- BMRA United States
- Employees
- CLDI N/A
- BMRA N/A
- Industry
- CLDI Biotechnology: Biological Products (No Diagnostic Substances)
- BMRA Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- CLDI Health Care
- BMRA Health Care
- Exchange
- CLDI Nasdaq
- BMRA Nasdaq
- Market Cap
- CLDI 9.3M
- BMRA 7.4M
- IPO Year
- CLDI N/A
- BMRA N/A
- Fundamental
- Price
- CLDI $1.15
- BMRA $0.35
- Analyst Decision
- CLDI Strong Buy
- BMRA
- Analyst Count
- CLDI 3
- BMRA 0
- Target Price
- CLDI $16.67
- BMRA N/A
- AVG Volume (30 Days)
- CLDI 111.5K
- BMRA 994.2K
- Earning Date
- CLDI 08-13-2024
- BMRA 10-11-2024
- Dividend Yield
- CLDI N/A
- BMRA N/A
- EPS Growth
- CLDI N/A
- BMRA N/A
- EPS
- CLDI N/A
- BMRA N/A
- Revenue
- CLDI N/A
- BMRA $5,415,000.00
- Revenue This Year
- CLDI N/A
- BMRA N/A
- Revenue Next Year
- CLDI N/A
- BMRA N/A
- P/E Ratio
- CLDI N/A
- BMRA N/A
- Revenue Growth
- CLDI N/A
- BMRA 1.42
- 52 Week Low
- CLDI $0.14
- BMRA $0.24
- 52 Week High
- CLDI $8.00
- BMRA $2.13
- Technical
- Relative Strength Index (RSI)
- CLDI 34.87
- BMRA 41.31
- Support Level
- CLDI $1.09
- BMRA $0.43
- Resistance Level
- CLDI $1.17
- BMRA $0.47
- Average True Range (ATR)
- CLDI 0.09
- BMRA 0.06
- MACD
- CLDI -0.01
- BMRA -0.00
- Stochastic Oscillator
- CLDI 25.69
- BMRA 14.21
About CLDI Calidi Biotherapeutics Inc.
Calidi Biotherapeutics Inc is a clinical stage immuno-oncology company pioneering the development and commercialization of novel, potent and efficient stem cell-based platforms for delivery and potentiation of oncolytic viruses for the treatment of cancer.
About BMRA Biomerica Inc.
Biomerica Inc is engaged in the development, manufacturing, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. It operates in one segment namely, the design, development, marketing and sales of diagnostic kits. The majority of the company's revenue is earned from the Europe market.